| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1032661379 |
| P356 | DOI | 10.2165/00023210-200418130-00003 |
| P698 | PubMed publication ID | 15521790 |
| P2093 | author name string | George T Grossberg | |
| Abhilash K Desai | |||
| Dharmesh N Sheth | |||
| P2860 | cites work | Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology | Q22241632 |
| Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
| FUNCTIONAL EVALUATION: THE BARTHEL INDEX | Q28201591 | ||
| Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial | Q28343193 | ||
| The Clinical Dementia Rating (CDR): current version and scoring rules | Q29616280 | ||
| Risk factors for functional status decline in community-living elderly people: a systematic literature review | Q33540768 | ||
| Clinical trials in Alzheimer's disease. A report from the Medical Research Council Alzheimer's Disease Clinical Trials Committee | Q33589344 | ||
| Outcome measures for the study of activities of daily living in vascular dementia | Q33803194 | ||
| Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. | Q33979412 | ||
| Executive cognitive impairment: a novel perspective on dementia | Q34074488 | ||
| The Gottfries-Bråne-Steen scale: validity, reliability and application in anti-dementia drug trials | Q34110191 | ||
| Review of outcome measurement instruments in Alzheimer's disease drug trials: psychometric properties of functional and quality of life scales | Q34112099 | ||
| Development and validation of the geriatric evaluation by relatives rating instrument (GERRI). | Q34265392 | ||
| Assessment of older people: self-maintaining and instrumental activities of daily living | Q66829682 | ||
| Predictors of the placement of cognitively impaired residents on special care units | Q68111255 | ||
| Scientific and clinical problems in indexes of functional disability | Q69584472 | ||
| Assessing the severity of dementia. Patient and caregiver | Q70112986 | ||
| The impact of dementia on the family | Q70377059 | ||
| Physical Performance Test and Activities of Daily Living scales in the assessment of health status in elderly people | Q70503451 | ||
| Relationships between impairment and physical disability as measured by the functional independence measure | Q70741809 | ||
| Development of the refined ADL Assessment Scale for patients with Alzheimer's and related disorders | Q72001680 | ||
| The Groningen Activity Restriction Scale for measuring disability: its utility in international comparisons | Q72127951 | ||
| On the paradox of improving sensitivity of ADL scales for the detection of behavioral changes in early dementia | Q72568492 | ||
| Comparing motor and process ability of persons with suspected dementia in home and clinic settings | Q72761692 | ||
| The Direct Assessment of Functional Abilities (DAFA): a comparison to an indirect measure of instrumental activities of daily living | Q74307056 | ||
| Psychiatric and physical morbidity effects of dementia caregiving: prevalence, correlates, and causes | Q34371058 | ||
| An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. | Q34433716 | ||
| Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration | Q34482413 | ||
| The disablement process: a conceptual framework for dementia-associated disability | Q34530824 | ||
| Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis | Q35040742 | ||
| Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations | Q35075401 | ||
| Systematic biases in functional status assessment of elderly adults: effects of different data sources. | Q36605373 | ||
| Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group | Q37369200 | ||
| Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living | Q40210134 | ||
| Correspondence of the functional independence measure (FIM) self-care subscale with real-time observations of dementia patients' ADL performance in the home | Q40661367 | ||
| Methodological issues in measuring the functional status of cognitively impaired nursing home residents: the use of proxies and performance-based measures. | Q40693277 | ||
| Clinical global impressions in Alzheimer's clinical trials. | Q41312794 | ||
| Disability and cognitive impairment in the elderly | Q41498916 | ||
| Assessing functioning and self-care abilities in Alzheimer disease research | Q41686208 | ||
| Formal education as an effect modifier of the relationship between Mini-Mental State Examination score and IADLs disability in the older population. | Q43331939 | ||
| The disability assessment for dementia scale: a 12-month study of functional ability in mild to moderate severity Alzheimer disease | Q43629186 | ||
| A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. | Q43705809 | ||
| A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease | Q43721304 | ||
| Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease | Q43747318 | ||
| Functional decline in older adults: expanding methods of ascertainment | Q43794937 | ||
| Measurement and prediction of functional capacity in Alzheimer's disease | Q43848058 | ||
| A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting | Q43885713 | ||
| Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial | Q43966701 | ||
| A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group | Q44110810 | ||
| Undetected dementia in community-dwelling older people: the Canadian Study of Health and Aging | Q44326530 | ||
| Memantine in moderate-to-severe Alzheimer's disease | Q44388745 | ||
| Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden | Q44447935 | ||
| Mental status as a predictor of daily function in progressive dementia | Q44547205 | ||
| Functional assessment of the elderly. A comparison of standard instruments with clinical judgment | Q44644106 | ||
| Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial | Q44735780 | ||
| AD2000: donepezil in Alzheimer's disease | Q44953768 | ||
| Emergent psychopathology in Alzheimer's disease patients over 12 months associated with functional, not cognitive, changes | Q46079295 | ||
| Structured assessment of independent living skills: preliminary report of a performance measure of functional abilities in dementia | Q46675745 | ||
| The Alzheimer's disease activities of daily living international scale (ADL-IS). | Q47614763 | ||
| Cognitive impairment and functional disability in the absence of psychiatric diagnosis | Q48798553 | ||
| The disablement process | Q48853759 | ||
| Use of neuropsychological tests to predict adult patients' everyday functioning | Q49143591 | ||
| The Bayer-Activities of Daily Living Scale (B-ADL): results from a validation study in three European countries | Q49245440 | ||
| Functional decline in Alzheimer's disease: a longitudinal study. | Q50609494 | ||
| Combining activities of daily living with instrumental activities of daily living to measure functional disability. | Q50907708 | ||
| The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. | Q51183354 | ||
| Longitudinal assessment of patient dependence in Alzheimer disease. | Q51953992 | ||
| Correlates of disability among elderly retirees with "subclinical" cognitive impairment. | Q51973843 | ||
| The sensitivity to change over time of the Bristol Activities of Daily Living Scale in Alzheimer's disease. | Q51975281 | ||
| The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group. | Q52006733 | ||
| Modeling the influence of extrapyramidal signs on the progression of Alzheimer disease. | Q52006756 | ||
| Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale. | Q52009228 | ||
| Documentation and evaluation of cognitive impairment in elderly primary care patients. | Q52017609 | ||
| Canadian guidelines for the development of antidementia therapies: a conceptual summary. | Q52018850 | ||
| The Clinician Interview-Based Impression (CIBI): a clinician's global change rating scale in Alzheimer's disease. | Q52021320 | ||
| Mild cognitive impairment: transition between aging and Alzheimer's disease. | Q52026575 | ||
| A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group. | Q52026922 | ||
| The perspective of the patient with Alzheimer's disease: a neglected dimension of dementia research. | Q52037084 | ||
| Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers. | Q52040965 | ||
| Aging, memory, and mild cognitive impairment. | Q52044622 | ||
| A correlation between cognitive performance and daily functioning in elderly people. | Q52065915 | ||
| Measurement of functional activities in older adults in the community. | Q52098675 | ||
| A new scale for the assessment of functional status in Alzheimer's disease and related disorders. | Q52114817 | ||
| Dementia: characteristics of a referral population and factors associated with progression. | Q52122934 | ||
| STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. | Q52137534 | ||
| A new clinical scale for the staging of dementia. | Q52220854 | ||
| Metrifonate therapy in Alzheimer's disease: a pooled analysis of four randomized, double-blind, placebo-controlled trials. | Q52580084 | ||
| Measuring functioning in daily activities for persons with dementia. | Q52900097 | ||
| Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. | Q52915655 | ||
| Interrater reliability of the Physical Self-Maintenance Scale and the Instrumental Activities of Daily Living Scale in a variety of health professional representatives. | Q52933981 | ||
| Functional assessment staging (FAST) in Alzheimer's disease: reliability, validity, and ordinality. | Q53180132 | ||
| Measurement of quality-of-life changes in patients with Alzheimer's disease. | Q53189115 | ||
| Assessing patient dependence in Alzheimer's disease. | Q53205920 | ||
| Time until institutionalization and death in patients with dementia. Role of caregiver training and risk factors. | Q53210001 | ||
| Activities of daily living as an outcome measure in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. | Q53219306 | ||
| Functional disability in Alzheimer's disease. | Q53221030 | ||
| The Bayer Activities of Daily Living Scale (B-ADL). | Q53223956 | ||
| The effects of donepezil in Alzheimer's disease - results from a multinational trial. | Q53228615 | ||
| Second International Pharmacoeconomic Conference on Alzheimer' s Disease. | Q53237716 | ||
| The prevalence, assessment and associations of falls in dementia with Lewy bodies and Alzheimer's disease. | Q53333743 | ||
| Diagnosing dementia: perspectives of primary care physicians. | Q53337305 | ||
| Predicting conversion to Alzheimer disease using standardized clinical information. | Q53340763 | ||
| Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group. | Q53341838 | ||
| A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group. | Q53341841 | ||
| Promoting well-being and independence for people with dementia. | Q53518157 | ||
| Progress in Development of the Index of ADL | Q56004802 | ||
| The Global Deterioration Scale for assessment of primary degenerative dementia | Q57279034 | ||
| An efficacy and safety analysis of Exelon in Alzheimer's disease patients with concurrent vascular risk factors | Q58748656 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dementia | Q83030 |
| P304 | page(s) | 853-875 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | CNS Drugs | Q5013183 |
| P1476 | title | Activities of daily living in patients with dementia: clinical relevance, methods of assessment and effects of treatment | |
| P478 | volume | 18 |
| Q38269098 | A qualitative review of instrumental activities of daily living in dementia: what's cooking? |
| Q46521443 | Accuracy statistics in predicting Independent Activities of Daily Living (IADL) capacity with comprehensive and brief neuropsychological test batteries |
| Q48113697 | Actual reality: Using the Internet to assess everyday functioning after traumatic brain injury |
| Q35574508 | Adding memantine to rivastigmine therapy in patients with mild-to-moderate alzheimer's disease: results of a 12-week, open-label pilot study |
| Q50573810 | Adherence to Medication Regimens is an Effective Indicator of Cognitive Dysfunction in Elderly Individuals. |
| Q44056561 | An informant questionnaire for detecting Alzheimer's disease: are some items better than others? |
| Q42399307 | Are we comparing frontotemporal dementia and Alzheimer disease patients with the right measures? |
| Q39837265 | Assessing the cost-effectiveness of the rivastigmine transdermal patch for Alzheimer's disease in the UK using MMSE- and ADL-based models |
| Q38913493 | Assessment of Activities of Daily Living, Self-Care, and Independence |
| Q45156627 | Assessment of instrumental activities of daily living in dementia: diagnostic value of the Amsterdam Instrumental Activities of Daily Living Questionnaire |
| Q33936453 | Back propagation artificial neural network for community Alzheimer's disease screening in China |
| Q34175825 | Cerebral atrophy, apolipoprotein E ɛ4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment |
| Q92523174 | Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease |
| Q38735652 | Cognitive Rehabilitation in Alzheimer's Disease: A Controlled Intervention Trial |
| Q51981444 | Cognitive impairment and carotid atherosclerosis in a general Italian midlife and old population. |
| Q94326695 | Comparing Differences in ADL Outcomes for the STOMP Intervention for Dementia in the Natural Home Environment Versus a Clinic Environment |
| Q46313588 | Comprehensive geriatric assessment in elderly outpatients with dementia |
| Q24599735 | Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease |
| Q46964545 | Cross-cultural adaptation, reliability and validity of the DAFS-R in a sample of Brazilian older adults. |
| Q81924610 | Current awareness in geriatric psychiatry |
| Q37042753 | Daily Activity Abilities in MCI, Alzheimer's Disease, and Healthy Controls |
| Q44300416 | Depressive Symptoms and Use of Home-Based Respite Time in Family Caregivers |
| Q34974708 | Development and psychometric properties of the instrumental activities of daily living: compensation scale |
| Q50672089 | Development of an instrument for measuring activities of daily living in persons with suspected cognitive impairment. |
| Q35268449 | Disability but not social support predicts cognitive deterioration in late-life depression |
| Q44259357 | Disability in instrumental activities of daily living in elderly patients with mild cognitive impairment and Alzheimer's disease |
| Q53329844 | Effects of resistance training on the performance of activities of daily living in patients with Alzheimer's disease. |
| Q36165980 | Efficacy of 13.3 mg/24 h versus 4.6 mg/24 h rivastigmine patch on activities of daily living in severe Alzheimer's disease |
| Q53050714 | Efficacy of rivastigmine transdermal patch on activities of daily living: item responder analyses. |
| Q34779300 | Examining the impact of familiarity on faucet usability for older adults with dementia |
| Q37378501 | From cognitive neuroscience to geriatric neuropsychology: what do current conceptualizations of the action error handling process mean for older adults? |
| Q50647134 | Functional disability in Alzheimer disease: a validation study of the Turkish version of the disability assessment for dementia scale. |
| Q37081625 | Greater Independence in Activities of Daily Living is Associated with Higher Health-Related Quality of Life Scores in Nursing Home Residents with Dementia |
| Q40070131 | Health outcomes and quality of life of residents of shared-housing arrangements compared to residents of special care units - results of the Berlin DeWeGE-study. |
| Q35942354 | Impact of physical activity on activity of daily living in moderate to severe dementia: a critical review |
| Q35676394 | Instrumental activities of daily living performance and role satisfaction in people with and without mild cognitive impairment: a pilot project |
| Q38853009 | Interrater Reliability and Concurrent Validity of a New Rating Scale to Assess the Performance of Everyday Life Tasks in Dementia: The Core Elements Method |
| Q43652326 | Interview for Deterioration in Daily Living Activities in Dementia: construct and concurrent validity in patients with mild to moderate dementia |
| Q95840807 | Is Barthel Index Suitable for Assessing Activities of Daily Living in Patients With Dementia? |
| Q89075763 | Is Episodic Future Thinking Important for Instrumental Activities of Daily Living? A Study in Neurological Patients and Healthy Older Adults |
| Q52312837 | Measuring the Kinematics of Daily Living Movements with Motion Capture Systems in Virtual Reality. |
| Q35218713 | Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review |
| Q46884285 | Participant-Informant Relationships Affect Quality of Life Ratings in Incipient and Clinical Alzheimer Disease |
| Q47578621 | Perceptions of risk and prevention of dementia in the healthy elderly |
| Q37613828 | Precipitating and predisposing events and symptoms for admission to assisted living or nursing home care |
| Q51558760 | Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment. |
| Q90354486 | Robot-Enabled Support of Daily Activities in Smart Home Environments |
| Q46223001 | Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial |
| Q47612197 | Smart Secure Homes: A Survey of Smart Home Technologies that Sense, Assess, and Respond to Security Threats |
| Q52609775 | Structural Anatomical Investigation of Long-Term Memory Deficit in Behavioral Frontotemporal Dementia. |
| Q33568361 | The need for harmonisation and innovation of neuropsychological assessment in neurodegenerative dementias in Europe: consensus document of the Joint Program for Neurodegenerative Diseases Working Group |
| Q50851631 | Validation of the Amsterdam IADL Questionnaire©, a new tool to measure instrumental activities of daily living in dementia. |
| Q37348802 | Validation of the dementia care assessment packet-instrumental activities of daily living |
| Q47946382 | Welcome Back to Your Future: The Assessment of Dementia by the Latent Variable "δ". |
| Q45906072 | What are the top-circulating magazines in the United States telling older adults about cognitive health? |
| Q53029167 | [Cross-cultural adaptation of the Disability Assessment for Dementia (DAD)]. |
Search more.